Table 3 The MPP2 mutations in 2081 VKH patients by target region sequencing (TRS)

From: A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing

AAChange

cDNAchange

exon

Mutations(frequency)

Gene

ExonicFunc

A5T

G13A

exon1

5/4162

NM_001278372

nonsynonymous SNV

S15C

C44G

exon1

25/4162

NM_001278376

nonsynonymous SNV

E26A

A77C

exon1

2/4162

NM_001278370

nonsynonymous SNV

W30X

G89A

exon1

26/4162

NM_001278370

stopgain SNV

W30X

G90A

exon1

1/4162

NM_001278370

stopgain SNV

L41F

C121T

exon2

1/4162

NM_001278370

nonsynonymous SNV

L41P

T122C

exon2

1/4162

NM_001278370

nonsynonymous SNV

N61I

A182T

exon4

1/4162

NM_001278372

nonsynonymous SNV

T82M

C245T

exon5

1/4162

NM_001278372

nonsynonymous SNV

P158L

C473T

exon6

1/4162

NM_001278372

nonsynonymous SNV

G172R

G514A

exon6

1/4162

NM_001278372

nonsynonymous SNV

R222H

G665A

exon7

1/4162

NM_001278372

nonsynonymous SNV

P246S

C736T

exon7

1/4162

NM_001278372

nonsynonymous SNV

H247Y

C739T

exon7

1/4162

NM_001278372

nonsynonymous SNV

K271E

A811G

exon8

1/4162

NM_001278372

nonsynonymous SNV

G335S

G1003A

exon10

1/4162

NM_001278372

nonsynonymous SNV

R387Q

G1160A

exon11

2/4162

NM_001278372

nonsynonymous SNV

T409A

A1225G

exon12

1/4162

NM_001278372

nonsynonymous SNV

Y423S

A1268C

exon12

1/4162

NM_001278372

nonsynonymous SNV

N473S

A1418G

exon12

1/4162

NM_001278372

nonsynonymous SNV

A507V

C1520T

exon13

1/4162

NM_001278372

nonsynonymous SNV

R524Q

G1571A

exon14

1/4162

NM_001278372

nonsynonymous SNV

E527G

A1580G

exon14

1/4162

NM_001278372

nonsynonymous SNV

P567L

C1700T

exon14

1/4162

NM_001278372

nonsynonymous SNV